Verisk terminates definitive agreement to acquire AccuLynx

Verisk terminated its definitive agreement to purchase AccuLynx. This decision follows the notification by the Federal Trade Commission that it has not completed its review of the transaction by the December 26 termination date set forth in the agreement. The Company also announced that it will redeem the $1.5B aggregate principal amount of senior notes that were issued in connection with the planned acquisition for a price equal to 101% of their principal amount plus accrued and unpaid interest to the redemption date. The redemption is required pursuant to a special mandatory redemption provision in the terms of the notes. Pro forma for the redemption of the notes, Verisk’s leverage at September 30, 2025 would have been 1.9 times LTM adjusted EBITDA. As of September 30, Verisk had $1.2B of capacity remaining under its share repurchase authorization. Lee Shavel, CEO, stated, “Verisk remains committed to our capital allocation discipline – balancing organic investment in our highest return on capital opportunities while returning capital to shareholders through dividend and repurchases. We continue to have confidence in our ability to deliver results in line with our long-term growth targets for this year, for 2026 and beyond.” AccuLynx has notified Verisk that it believes Verisk’s termination of the merger agreement is invalid. Verisk strongly disagrees with this assertion and intends to vigorously defend against any such assertions.